Doxy 200

   
Google
 
Web NewDrugInformation.com

Doxy 200


Drug - Doxy 200
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Doxycycline Hyclate
Multiple ingredients are in alphabetical order.

Strength - EQ 200MG BASE/VIAL
The potency of the active ingredient(s), Doxycycline Hyclate. May repeat for multiple part products.

Applicant - AM PHARM PARTNERS
The firm name holding legal responsibility for Doxy 200. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062475
The FDA assigned number to Doxy 200. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Doxy 200. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 9, 1983
The date Doxy 200 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Doxy 200. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Doxy 200 is in. Format is RX, OTC, DISCN.

Applicant Full Name - American Pharmaceutical Partners Inc
The full name of the firm holding legal responsibility for the new application of Doxy 200.

Doxy 200